Disparate rates of enrollment of racial and ethnic minorities and medically underserved populations in clinical trials is well documented. This under representation not only impacts the validity of trial results but increases health disparities for under-served communities and patients.
Join key stakeholders for solution driven discussions around improving clinical trial diversity via the implementation of actionable strategies from the planning, design and execution of clinical trials.
It is time to make health equity in clinical trials a reality. Participate with key players to achieve this objective via forging new cross stakeholder relationships, lines of communication and strategic community & advocacy partnerships.
Senior Director, Team Lead, Advocacy and Professional Relations, Pfizer Oncology
Inclusion Principal, External Partnering
Patient Care Navigator, Breast Cancer, Ambulatory Speciality Care
Alameda Health System
LaTasha Lee PhD.
Vice President, Social and Clinical Research & Development
National Minority Quality Forum
Head of Diversity Strategy
Bristol Myers Squibb